Humanized antibody-cytokine fusion protein demonstrates immunological activity in phase I trial May 26, 1999
MDX-447 shows promising biological activity in phase I/II trial, results reported at ASCO meeting May 25, 1999
News from ASCO: phase I trial of PNU-214565 dose escalation tied to baseline anti-SEA antibodies May 21, 1999
RSS